TY - JOUR
T1 - Value in Healthcare Initiative
T2 - Summary and Key Recommendations
AU - Joynt Maddox, Karen E.
AU - Bleser, William K.
AU - Das, Sandeep R.
AU - Desai, Nihar R.
AU - Ng-Osorio, Jackie
AU - O'Brien, Emily
AU - Psotka, Mitchell A.
AU - Wadhera, Rishi K.
AU - Weintraub, William S.
AU - Konig, Madeleine
N1 - Funding Information:
Dr Joynt Maddox receives research support from the National Heart, Lung, and Blood Institute (R01HL143421) and National Institute on Aging (R01AG060935), and previously did contract work for the US Department of Health and Human Services. Dr Bleser has previously received consulting fees from Merck on vaccine litigation unrelated to this work and serves as Board Vice President (uncompensated) for Shepherd’s Clinic, a clinic providing free healthcare to the uninsured in Baltimore, MD. Dr Desai works under contract with the Centers for Medicare and Medicaid Services to develop and maintain performance measures used for public reporting and pay for performance programs, and he reports consulting for Amgen, Boehringer Ingelheim, Cyto-kinetics, Medicines Company, Relypsa, Novartis, and SCPharmaceuticals. Dr O’Brien reports research grants from BMS and Novartis. Dr Psotka has received consulting fees from Amgen, Cytokinetics, and Windtree and receives a research fellowship from the US Food and Drug Administration. Dr Wadhera receives research support from the National Heart, Lung, and Blood Institute (grant K23HL148525-1) at the National Institutes of Health. He previously served as a consultant for Regeneron, outside the submitted work. The other authors report no conflicts.
Funding Information:
The Value in Healthcare Initiative is a collaboration of the American Heart Association and the Robert J. Margolis, MD, Center for Health Policy at Duke University. The Value in Healthcare Initiative is supported in part by the American Heart Association and industry partners (Amgen, Bristol-Myers Squibb, the Bristol-Myers Squibb-Pfizer Alliance, and the Sanofi-Regeneron Alliance).
Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - In spring 2018, the American Heart Association convened the Value in Healthcare Summit to begin an important conversation about the challenges patients with cardiovascular disease face in accessing and deriving quality and value from the healthcare system. Following the summit and recognizing the collective momentum it created, the American Heart Association, in collaboration with the Robert J. Margolis Center for Health Policy at Duke University, launched the Value in Healthcare Initiative - Transforming Cardiovascular Care. Four areas of focus were identified, and learning collaboratives were established and proceeded to conduct concrete, actionable problem solving in 4 high-impact areas in cardiovascular care: Value-Based Models, Partnering with Regulators, Predict and Prevent, and Prior Authorization. The deliverables from these groups are being disseminated in 4 stand-alone articles, and their publication will initiate further work to test and evaluate each of these promising areas of reform. This article provides an overview of the initiative's findings and highlights key cross-cutting themes for consideration as the initiative moves forward.
AB - In spring 2018, the American Heart Association convened the Value in Healthcare Summit to begin an important conversation about the challenges patients with cardiovascular disease face in accessing and deriving quality and value from the healthcare system. Following the summit and recognizing the collective momentum it created, the American Heart Association, in collaboration with the Robert J. Margolis Center for Health Policy at Duke University, launched the Value in Healthcare Initiative - Transforming Cardiovascular Care. Four areas of focus were identified, and learning collaboratives were established and proceeded to conduct concrete, actionable problem solving in 4 high-impact areas in cardiovascular care: Value-Based Models, Partnering with Regulators, Predict and Prevent, and Prior Authorization. The deliverables from these groups are being disseminated in 4 stand-alone articles, and their publication will initiate further work to test and evaluate each of these promising areas of reform. This article provides an overview of the initiative's findings and highlights key cross-cutting themes for consideration as the initiative moves forward.
KW - American Heart Association
KW - cardiovascular disease
KW - leadership
KW - quality
KW - value
UR - http://www.scopus.com/inward/record.url?scp=85088610522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088610522&partnerID=8YFLogxK
U2 - 10.1161/CIRCOUTCOMES.120.006612
DO - 10.1161/CIRCOUTCOMES.120.006612
M3 - Article
C2 - 32683984
AN - SCOPUS:85088610522
SN - 1941-7713
VL - 13
SP - E006612
JO - Circulation: Cardiovascular Quality and Outcomes
JF - Circulation: Cardiovascular Quality and Outcomes
IS - 7
ER -